Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Tenet Healthcare Corp (NYSE: THC) closed the day trading at $153.02 up 3.13% from the previous closing price of $148.38. In other words, the price has increased by $3.13 from its previous closing price. On the day, 1.98 million shares were traded. THC stock price reached its highest trading level at $153.145 during the session, while it also had its lowest trading level at $146.6.
Ratios:
For a better understanding of THC, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.41 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.15. For the most recent quarter (mrq), Quick Ratio is recorded 1.63 and its Current Ratio is at 1.71. In the meantime, Its Debt-to-Equity ratio is 3.51 whereas as Long-Term Debt/Eq ratio is at 3.49.
On April 15, 2025, Robert W. Baird Downgraded its rating to Neutral which previously was Outperform but kept the price unchanged to $137.
On March 26, 2025, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $165.Morgan Stanley initiated its Overweight rating on March 26, 2025, with a $165 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 05 ’25 when FISHER RICHARD W sold 836 shares for $173.16 per share. The transaction valued at 144,762 led to the insider holds 11,292 shares of the business.
Arbour Paola M sold 7,738 shares of THC for $1,338,674 on Jun 05 ’25. The EVP, Chief Information Officer now owns 20,110 shares after completing the transaction at $173.00 per share. On Jun 05 ’25, another insider, Arbour Paola M, who serves as the Officer of the company, bought 7,738 shares for $173.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, THC now has a Market Capitalization of 14213263360 and an Enterprise Value of 29048477696. As of this moment, Tenet’s Price-to-Earnings (P/E) ratio for their current fiscal year is 9.79, and their Forward P/E ratio for the next fiscal year is 9.76. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.78. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.69 while its Price-to-Book (P/B) ratio in mrq is 3.40. Its current Enterprise Value per Revenue stands at 1.404 whereas that against EBITDA is 6.672.
Stock Price History:
The Beta on a monthly basis for THC is 1.51, which has changed by 0.0009812117 over the last 52 weeks, in comparison to a change of 0.16932249 over the same period for the S&P500. Over the past 52 weeks, THC has reached a high of $185.25, while it has fallen to a 52-week low of $109.82. The 50-Day Moving Average of the stock is -8.89%, while the 200-Day Moving Average is calculated to be 4.94%.
Shares Statistics:
Over the past 3-months, THC traded about 1.71M shares per day on average, while over the past 10 days, THC traded about 2228330 shares per day. A total of 92.89M shares are outstanding, with a floating share count of 91.75M. Insiders hold about 1.22% of the company’s shares, while institutions hold 96.55% stake in the company. Shares short for THC as of 1752537600 were 2921016 with a Short Ratio of 1.71, compared to 1749772800 on 4133917. Therefore, it implies a Short% of Shares Outstanding of 2921016 and a Short% of Float of 4.16.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0The stock’s 5-year Average Dividend Yield is 2.75. The current Payout Ratio is 0.00% for THC, which recently paid a dividend on 2000-03-13 with an ex-dividend date of 2000-03-13. Stock splits for the company last occurred on 2012-10-11 when the company split stock in a 1:4 ratio.
Earnings Estimates
Investors are keenly observing as 19.0 analysts analyze and rate the current performance of Tenet Healthcare Corp (THC) in the stock market.The consensus estimate for the next quarter is $3.86, with high estimates of $4.35 and low estimates of $2.74.
Analysts are recommending an EPS of between $16.34 and $12.38 for the fiscal current year, implying an average EPS of $15.2. EPS for the following year is $15.52, with 21.0 analysts recommending between $17.56 and $11.58.
Revenue Estimates
18 analysts predict $5.23B in revenue for the current quarter. It ranges from a high estimate of $5.35B to a low estimate of $5.1B. As of the current estimate, Tenet Healthcare Corp’s year-ago sales were $5.12BFor the next quarter, 18 analysts are estimating revenue of $5.37B. There is a high estimate of $5.52B for the next quarter, whereas the lowest estimate is $5.18B.
A total of 20 analysts have provided revenue estimates for THC’s current fiscal year. The highest revenue estimate was $21.41B, while the lowest revenue estimate was $20.77B, resulting in an average revenue estimate of $21.09B. In the same quarter a year ago, actual revenue was $20.66BBased on 20 analysts’ estimates, the company’s revenue will be $22.02B in the next fiscal year. The high estimate is $22.47B and the low estimate is $21.51B.
